High baseline Tie1 level predicts poor survival in metastatic breast cancer

L. Tiainen; E.A. Korhonen; V.-M. Leppänen; T. Luukkaala; M. Hämäläinen; M. Tanner; O. Lahdenperä; P. Vihinen; A. Jukkola; P. Karihtala; S. Aho; E. Moilanen; K. Alitalo; P.-L. Kellokumpu-Lehtinen

doi:10.1186/s12885-019-5959-8

High baseline Tie1 level predicts poor survival in metastatic breast cancer

L. Tiainen, E.A. Korhonen, V.-M. Leppänen, T. Luukkaala, M. Hämäläinen, M. Tanner, O. Lahdenperä, P. Vihinen, A. Jukkola, P. Karihtala, S. Aho, E. Moilanen, K. Alitalo, P.-L. Kellokumpu-Lehtinen

Research output: Contribution to journal › Article › Scientific › peer-review

5 Citations (Scopus)

Original language	English
Article number	732
Pages (from-to)	732
Journal	BMC Cancer
Volume	19
Issue number	1
DOIs	https://doi.org/10.1186/s12885-019-5959-8
Publication status	Published - 2019
Publication type	A1 Journal article-refereed

Keywords

Angiogenesis
Angiopoietin-2
Metastatic breast cancer
Prognostic marker
Tie1

Publication forum classification

Publication forum level 1

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/s12885-019-5959-8

http://urn.fi/urn:nbn:fi:tuni-201910113812

Cite this

Tiainen, L., Korhonen, E. A., Leppänen, V-M., Luukkaala, T., Hämäläinen, M., Tanner, M., Lahdenperä, O., Vihinen, P., Jukkola, A., Karihtala, P., Aho, S., Moilanen, E., Alitalo, K., & Kellokumpu-Lehtinen, P-L. (2019). High baseline Tie1 level predicts poor survival in metastatic breast cancer. BMC Cancer, 19(1), 732. Article 732. https://doi.org/10.1186/s12885-019-5959-8

@article{0ebe58a87169450f90e17eea148bc918,

title = "High baseline Tie1 level predicts poor survival in metastatic breast cancer",

keywords = "Angiogenesis, Angiopoietin-2, Metastatic breast cancer, Prognostic marker, Tie1, Angiogenesis, Angiopoietin-2, Metastatic breast cancer, Prognostic marker, Tie1",

author = "L. Tiainen and E.A. Korhonen and V.-M. Lepp{\"a}nen and T. Luukkaala and M. H{\"a}m{\"a}l{\"a}inen and M. Tanner and O. Lahdenper{\"a} and P. Vihinen and A. Jukkola and P. Karihtala and S. Aho and E. Moilanen and K. Alitalo and P.-L. Kellokumpu-Lehtinen",

year = "2019",

doi = "10.1186/s12885-019-5959-8",

language = "English",

volume = "19",

pages = "732",

journal = "BMC Cancer",

issn = "1471-2407",

publisher = "Springer Verlag",

number = "1",

}

TY - JOUR

T1 - High baseline Tie1 level predicts poor survival in metastatic breast cancer

AU - Tiainen, L.

AU - Korhonen, E.A.

AU - Leppänen, V.-M.

AU - Luukkaala, T.

AU - Hämäläinen, M.

AU - Tanner, M.

AU - Lahdenperä, O.

AU - Vihinen, P.

AU - Jukkola, A.

AU - Karihtala, P.

AU - Aho, S.

AU - Moilanen, E.

AU - Alitalo, K.

AU - Kellokumpu-Lehtinen, P.-L.

PY - 2019

Y1 - 2019

KW - Angiogenesis

KW - Angiopoietin-2

KW - Metastatic breast cancer

KW - Prognostic marker

KW - Tie1

KW - Angiogenesis

KW - Angiopoietin-2

KW - Metastatic breast cancer

KW - Prognostic marker

KW - Tie1

U2 - 10.1186/s12885-019-5959-8

DO - 10.1186/s12885-019-5959-8

M3 - Article

SN - 1471-2407

VL - 19

SP - 732

JO - BMC Cancer

JF - BMC Cancer

IS - 1

M1 - 732

ER -